Rheumatoid Arthritis Switching Patient Profile US 2018 Spotlight
We analyzed the charts of 1,074 US and 1,312 EU rheumatoid arthritis (RA) patients who were switched from one biologic or JAK-inhibitor to a different brand in the past three months. Here we highlight one patient record from Spherix’s RealWorld Dynamix: Biologic/JAK Switching in RA (US) audit, detailing the patient’s journey from diagnosis to their current switched treatment.
This complimentary infographic highlights “Rachel’s” RA patient journey – imagine what you could do with over 1,000 records just like hers to datamine for your brand!
Contact [email protected] for more information about the highlighted report or to see if your company already has access.
All company, brand or product names and logos in this document are trademarks of their respective holders.